DprE1-IN-4 is a potent non-covalent DprE1 inhibitor with strong in vitro activity against Mycobacterium tuberculosis H37Rv and drug-resistant strains (MIC = 0.12 μg/mL and 0.24 μg/mL, respectively); it demonstrates significant bactericidal efficacy in an acute murine model of pulmonary tuberculosis and exhibits acceptable pharmacokinetic properties.